Literature DB >> 10574080

Delusions in Alzheimer's disease: spet evidence of right hemispheric dysfunction.

R T Staff1, M F Shanks, L Macintosh, S J Pestell, H G Gemmell, A Venneri.   

Abstract

Delusional thinking and related behaviours are common symptoms in Alzheimer's disease (AD). The aim of the study was to determine if any consistent cerebral image pattern can be identified using Tc99m-hexamethylpropyleneamine (HMPAO) SPET in AD patients with and without delusions. 18 AD patients with delusion and 15 AD patients without delusion underwent neuropsychological testing and regional cerebral blood flow imaging using Tc99m-HMPAO SPET. The reconstructed data was compared using regions of interest drawn over each cerebral lobe and a statistical parametric mapping (SPM) approach. The neuropsychological testing showed that there was no difference in the profiles of the deluded and non deluded AD patients. The imaging results showed a significant degree of image asymmetry. This took the form of a right hemisphere hypoperfusion mainly in the right frontal and limbic regions. The results do not indicate a specific focal site of hypoperfusion in the patients with delusion. They do, however, indicate that delusions in AD may be associated with areas of hypoperfusion in the right anterior hemisphere.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10574080     DOI: 10.1016/s0010-9452(08)70818-9

Source DB:  PubMed          Journal:  Cortex        ISSN: 0010-9452            Impact factor:   4.027


  18 in total

1.  Clinical and imaging features of Othello's syndrome.

Authors:  J Graff-Radford; J L Whitwell; Y E Geda; K A Josephs
Journal:  Eur J Neurol       Date:  2011-04-25       Impact factor: 6.089

2.  Neurobiology of delusions, memory, and insight in Alzheimer disease.

Authors:  David L Sultzer; Lorraine P Leskin; Rebecca J Melrose; Dylan G Harwood; Theresa A Narvaez; Timothy K Ando; Mark A Mandelkern
Journal:  Am J Geriatr Psychiatry       Date:  2013-09-08       Impact factor: 4.105

3.  β-Amyloid 42/40 ratio and kalirin expression in Alzheimer disease with psychosis.

Authors:  Patrick S Murray; Caitlin M Kirkwood; Megan C Gray; Milos D Ikonomovic; William R Paljug; Eric E Abrahamson; Ruth A Henteleff; Ronald L Hamilton; Julia K Kofler; William E Klunk; Oscar L Lopez; Peter Penzes; Robert A Sweet
Journal:  Neurobiol Aging       Date:  2012-03-17       Impact factor: 4.673

Review 4.  Schizophrenia and monothematic delusions.

Authors:  Max Coltheart; Robyn Langdon; Ryan McKay
Journal:  Schizophr Bull       Date:  2007-03-19       Impact factor: 9.306

5.  Possible clinical anatomical features of right Alzheimer's disease (RAD).

Authors:  Carlo Abbate; Pietro D Trimarchi; Silvia Inglese; Emanuele Tomasini; Alessia Gallucci; Sarah Damanti; Simona Ciccone; Paolo D Rossi; Daniela Mari; Beatrice Arosio; Renzo Bagarolo; Fabrizio Giunco; Matteo Cesari
Journal:  Aging Clin Exp Res       Date:  2020-05-01       Impact factor: 3.636

6.  Neuroanatomical correlates of behavioural disorders in dementia.

Authors:  Howard J Rosen; Stephen C Allison; Guido F Schauer; Maria Luisa Gorno-Tempini; Michael W Weiner; Bruce L Miller
Journal:  Brain       Date:  2005-09-29       Impact factor: 13.501

7.  Accelerated atrophy in dopaminergic targets and medial temporo-parietal regions precedes the onset of delusions in patients with Alzheimer's disease.

Authors:  Riccardo Manca; Jose Manuel Valera-Bermejo; Annalena Venneri
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-05-13       Impact factor: 5.270

8.  TAR DNA-binding protein 43 pathology in Alzheimer's disease with psychosis.

Authors:  Anil Varma V Vatsavayi; Julia Kofler; Mary Ann A Demichele-Sweet; Patrick S Murray; Oscar L Lopez; Robert A Sweet
Journal:  Int Psychogeriatr       Date:  2014-03-04       Impact factor: 3.878

Review 9.  Psychosis in Alzheimer's disease.

Authors:  Patrick S Murray; Sanjeev Kumar; Mary Ann A Demichele-Sweet; Robert A Sweet
Journal:  Biol Psychiatry       Date:  2013-10-06       Impact factor: 13.382

10.  Hyperphosphorylated tau is elevated in Alzheimer's disease with psychosis.

Authors:  Patrick S Murray; Caitlin M Kirkwood; Megan C Gray; Kenneth N Fish; Milos D Ikonomovic; Ronald L Hamilton; Julia K Kofler; William E Klunk; Oscar L Lopez; Robert A Sweet
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.